The new facilities offer 13,000 square feet of laboratory and office space that will support the company’s molecular diagnostic cancer testing services and research activities.
Bernhard Sixt, president and CEO of Agendia, said: “The expanded capacity of our laboratories at our new location will allow us to meet the growing worldwide demand for our clinical services as we expand into major markets, enhancing the company’s ability to serve the healthcare community.”